ArticleJournal of thoracic disease2025
Inclusion of anti-vascular therapy as a promising option for later-line treatment of malignant pleural mesothelioma: a retrospective study.
Keda Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.